CD69 and non-small cell lung carcinoma: NK cells in tumor tissues of patients with non-small-cell lung cancer (NSCLC) show distinct receptor expression patterns with lower expression of NKp30, NKp80, KIR2DL1, and KIR2DL2 and higher expression of NKp44, NKG2A, CD69, and HLA-DR [107].